Few studies have examined the effectiveness of these medications in stroke survivors as there is insufficient evidence to recommend the use of cholinesterase inhibitors, memantine nootropics, or cognitive rehabilitation for CD patients [7]. The gene discussed is BCHE; the disease is stroke disorder.